Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

thehindubusinessline.com - BL Mumbai Bureau - DRI search at Cipla involving imported pharma product
DRI search at Cipla involving imported pharma product
The HinduBusinessLine –

Updated - November 17, 2026 at 12:56 PM. | Mumbai Drugmaker Cipla said that the Directorate of Revenue Intelligence (Mumbai zonal unit) had conducted a search at its office in Vikhroli, Mumbai, and at its depot in Bhiwandi, Thane. The search on…

thehindubusinessline.com -  PTI - AstraZeneca Pharma India inks agreement with Strand Life Sciences to explore healthcare collaboration
AstraZeneca Pharma India inks agreement with Strand Life Sciences to explore healthcare collaboration
The HinduBusinessLine –

Updated - November 17, 2026 at 04:13 PM. | New Delhi, Nov 17 AstraZeneca Pharma India Ltd on Tuesday said it has signed a letter of intent (LoI) with Strand Life Sciences Pvt Ltd to explore opportunities to collaborate in healthcare in India.

marketbeat.com - NewAmsterdam Pharma Sees Unusually Large Options Volume (NASDAQ:NAMS)
NewAmsterdam Pharma Sees Unusually Large Options Volume (NASDAQ:NAMS)
MarketBeat –

NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) saw some unusual options trading on Tuesday. Traders acquired 7,505 call options on the company. This is an increase of approximately 962% compared to the typical volume of 707 call…

marketbeat.com - NewAmsterdam Pharma Sees Unusually High Options Volume (NASDAQ:NAMS)
NewAmsterdam Pharma Sees Unusually High Options Volume (NASDAQ:NAMS)
MarketBeat –

NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) was the target of some unusual options trading on Tuesday. Stock traders purchased 7,505 call options on the company. This is an increase of 962% compared to the typical volume of 707…

marketbeat.com - Avalyn Pharma (NASDAQ:AVLN) Stock Falls 8.1% Following Analyst Downgrade
Avalyn Pharma (NASDAQ:AVLN) Stock Falls 8.1% Following Analyst Downgrade
MarketBeat –

Avalyn Pharma Inc. (NASDAQ:AVLN - Get Free Report) traded down 8.1% on Tuesday after Morgan Stanley lowered their price target on the stock from $57.00 to $53.00. Morgan Stanley currently has an overweight rating on the stock. Avalyn Pharma traded…

marketbeat.com - Avalyn Pharma (NASDAQ:AVLN) Share Price Crosses Below Fifty Day Moving Average on Analyst Downgrade
Avalyn Pharma (NASDAQ:AVLN) Share Price Crosses Below Fifty Day Moving Average on Analyst Downgrade
MarketBeat –

Avalyn Pharma Inc. (NASDAQ:AVLN - Get Free Report) shares passed below its 50-day moving average during trading on Tuesday after Morgan Stanley lowered their price target on the stock from $57.00 to $53.00. The stock has a 50-day moving average of…

thehindubusinessline.com - KS Badri Narayanan - Stocks to watch, Nov 18: ArMee Info, IIFL Finance, RITES, Supreme Petrochem, Glenmark, Mankind Pharma, Ashok Buildcon, Advait Energy, Apollo Micro, Nykaa
Stocks to watch, Nov 18: ArMee Info, IIFL Finance, RITES, Supreme Petrochem, Glenmark, Mankind Pharma, Ashok Buildcon, Advait Energy, Apollo Micro, Nykaa
The HinduBusinessLine –

RITES has entered into an MoU with National Mission for Clean Ganga [an authority under the Environment (Protection) Act, 1986 (EPA)]. This MoU will establish a long term working mechanism between RITES and NMCG to collaborate on the preparation of…

marketbeat.com - Teachers Retirement System of The State of Kentucky Buys 415,100 Shares of Royalty Pharma PLC $RPRX
Teachers Retirement System of The State of Kentucky Buys 415,100 Shares of Royalty Pharma PLC $RPRX
MarketBeat –

Teachers Retirement System of The State of Kentucky acquired a new stake in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) in the third quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired…

seekingalpha.com - Albert Anthony - One Liberty Properties: Upgrade After Q3, As Industrial Portfolio Grows Selectively
One Liberty Properties: Upgrade After Q3, As Industrial Portfolio Grows Selectively
Seeking Alpha –

Albert Anthony is the pen name of a business author on Amazon and a contributing analyst to investing platforms like Seeking Alpha since 2023, where he has over + 2,000 followers and has covered hundreds of stocks in multiple sectors including…

seekingalpha.com - Fred Piard - PJP: Healthcare Sector Dashboard For November
PJP: Healthcare Sector Dashboard For November
Seeking Alpha –

The healthcare equipment industry is undervalued based on historical averages, while pharma/biotechnology is significantly overvalued. Invesco Pharmaceuticals ETF (PJP) offers multi-factor pharmaceutical exposure suited to long-term and tactical…

techcrunch.com - Ram Iyer - Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials
Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials
TechCrunch –

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised $5 billion in a Series C funding round as it seeks to take its drug candidates to clinical trials. The funding was co-led by Greenoaks and…

crunchbase.com - Mary Ann Azevedo - PwC's IPO Lead On A Selective Market, AI Valuations And The Outlook For 2027
PwC's IPO Lead On A Selective Market, AI Valuations And The Outlook For 2027
Crunchbase –

The U.S. IPO market has rebounded, but the recovery remains uneven. Companies seeking to go public face investors focused on durable revenue, profitability and valuation, while uncertainty has prompted some issuers to postpone their offerings. Mike…

thehindubusinessline.com - Team BL - Stock Market Today Live: Stock to buy today: Cemindia Projects (₹1,353) - BUY
Stock Market Today Live: Stock to buy today: Cemindia Projects (₹1,353) - BUY
The HinduBusinessLine –

Indian stock markets are set to open weak amid mixed global cues, with Gift Nifty signaling a gap-down as consolidation dominates. Stocks to watch on Nov 18: ArMee, IIFL Finance, RITES, Supreme Petrochem, Glenmark, Mankind Pharma, Ashok Buildcon…

seekingalpha.com - Galzus Research - Immunome: De-Risked With The FDA, With An Admirably Deep Clinical Bench
Immunome: De-Risked With The FDA, With An Admirably Deep Clinical Bench
Seeking Alpha –

I maintain a Buy on Immunome, Inc.: its $2.1 billion market cap leaves upside versus the Springworks acquisition valuation. Varegacestat's phase 3 progression-free survival hazard ratio was 0.16; the FDA decision is due April 28, 2027, though…

forbes.com - Kimberley Jane Barnes - Turning Scientific Breakthroughs In CGT Into Patient Benefits
Turning Scientific Breakthroughs In CGT Into Patient Benefits
Forbes –

Kimberley Barnes is President of  Phacilitate, uniting the global advanced therapies ecosystem. ​From targeting and modifying cancer cells to treating genetic disorders, cell and gene therapies (CGT) promise health outcomes once…

Receive a Daily briefing on Pharma Industry News

Get Started